Kevin D’Silva: Chairman
    Kevin’s career has been in the life science products and the medical devices industries where he has been CEO and Chairman of several private and quoted companies. He is currently Chairman of Surface Transforms plc (AIM listed), AI2 Ltd (Private), and Oxford Cryosystems Ltd (Private),  and a Director of Acuity VCT 3 PLC (Public) and Titan VCT PLC (Public). Through a consultancy partnership, Salusinvest LP, he advises a number of EU and US listed companies. He is a chemical engineer from Leeds University and has an MBA from Manchester Business School.

Jos Belgrave: CEO
    Jos joined Hallmarq in January 2009 and succeeded James Otter as CEO in January 2010. He has 13 years experience as an equine vet developing a large hospital practice in Arundel, UK. Since selling his practice he has co-founded Vetstream, an online information service for vets around the world; worked for Intervet at their head office in The Netherlands as well as working in the human healthcare market in various roles.

Dr. Nick Bolas: Founder Director
    Nick led technical development from the foundation of the company, and currently manages vet training and relations. Nick has been developing, selling and supporting MRI systems for 19 years. Beginning with MR imaging at Oxford University he has subsequently designed and developed systems for a wide range of applications, and has had full P&L and sales responsibility for £4 million MRI business. Subsequently a Chief Scientist in Marconi Medical, he has a D.Phil (Oxon) and MBA, and is a horse owner and rider.

Dr. Steve Roberts: Technical Director
    Steve has many years experience of developing MRI systems and clinical MRI applications. He has a PhD in MRI Physics and has held several management positions, including MRI Applications Manager (SMIS Ltd), and Business Development Director (PulseTeq Ltd).

Larry Sargent: Finance Director
    Larry (FCCA) heads the finance function. He has held FD positions in several private and listed industrial companies, and has extensive experience of managing change in rapidly developing organisations.

Douglas Hutchison: Non executive Director

   Douglas qualified as a veterinary surgeon in 1980, and after three years in general practice he worked in the pharmaceutical and biotechnology industries within increasing leadership roles, ultimately as CEO of a biotechnology company, based in Cambridge.

In 1990, he founded Veterinary Business Development which grew to be one of the largest communications companies in the veterinary sector worldwide.  This published market-leading titles such as Veterinary Times and The Veterinary Business Journal and was sold successfully to the global corporation, Wolters Kluwer, in 2000.

Since that time, he has invested in a number of early stage companies in a variety of sectors and acts as a non-executive director in some.  He is Chairman of BioMedical Business Partners; The Private Investors’ Group; VetpulseTV; Photique Images; and is a partner in US-based publisher Veterinary Solutions LLC.  He is a former director of the British Veterinary Association; and former trustee of VETAID.  He was recruited as a Partner in the global executive search firm, Odgers Berndtson, in 2005.

Dan Brown: US Business Development Director
    Dr Dan Brown is Business Development Director for the USA and Canada. Dan is a veterinarian with equine, general practice and commercial experience.

Dr. Mat Hass: US Operations
    Mat is responsible for Hallmarq operations in America. He has a PhD in applied physics and has worked extensively in the MRI industry.

Victor Coles: Financial Controller
    Victor (FCA) has had a lifetime career in auditing and accounting. Until 2005 he was an audit partner in Cloke & Co based in the City of London.

James Otter: Board Observer
    James joined the company in Q4 2006. He was an observer at the Hallmarq Board during 2006, representing Hygea VCT an institutional investor in Hallmarq, and has now returned to this role after three years as CEO of Hallmarq. He is the Chairman of Hygea VCT and is also a director of a number of UK life science companies. After a career in international marketing and management at Zeneca Agrochemicals (formerly ICI and now Syngenta) he has led a range of smaller engineering and bioscience companies. As a main board director of Spectris plc he led the turnaround of their largest subsidiary, specializing in sound and vibration instrumentation in Denmark. He has an MA in Natural Sciences from Cambridge and an MBA from INSEAD, and speaks fluent French.